about
Genetic engineering of a modified herpes simplex virus 1 vaccine vector.Medical application of herpes simplex virus.GSK2656157, a PERK inhibitor, reduced LPS-induced IL-1β production through inhibiting Caspase 1 activation in macrophage-like J774.1 cells.Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.Livedoid vasculopathy and popliteal artery occlusion in a patient with protein S deficiency.Plaque type herpetic folliculitis involving the eccrine gland: immunohistochemical analysis.Actin-binding protein, Espin: a novel metastatic regulator for melanoma.Three cases of herpetic folliculitis causes by varicella-zoster virus: Immunohistochemical analysis.Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.Corneal infection of herpes simplex virus type 2--induced neuronal apoptosis in the brain stem of mice with expression of tumor suppressor gene (p53) and transcription factors.Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma.Deficient stratum corneum intercellular lipid in a Japanese patient with lamellar ichthyosis with a homozygous deletion mutation in SDR9C7.Eosinophilic annular erythema localized on the neck.Morphological analyses in fragility of pili torti with Björnstad syndrome.A case of Björnstad syndrome caused by novel compound heterozygous mutations in the BCS1L gene.Lymphoepithelioma-like carcinoma of the skin with potential for sweat glandular differentiation.An actin-binding protein espin is a growth regulator for melanoma.Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.A case of lung cancer with unilateral anhidrosis and contralateral hyperhidrosis as the first clinical manifestation.The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis.Case of Gianotti-Crosti syndrome following varicella zoster virus vaccinationOncolytic Virotherapy by HSVCD109 expression levels in malignant melanoma.Keratoacanthoma centrifugum marginatum arising from a scar after skin injuryPhotodynamic therapy for recurrent sarcoid flexor tenosynovitis of the fingerPhotodynamic therapy for the treatment of actinic cheilitisInfliximab treatment of severe genital ulcers associated with Behçet diseaseAcute hypersensitivity to dentifriceOral allergy syndrome with severe anaphylaxis induced by pistachioPigmented mammary Paget disease mimicking melanoma on dermatoscopyA case of cutaneous type pemphigus vulgarisAnalysis of family history of palmoplantar hyperhidrosis in JapanGranulomatous pigmented purpuric dermatosis containing Propionibacterium acnesLeg ulcers associated with cutaneous vascular degeneration in a patient receiving pazopanib chemotherapyTwo cases of refractory nail psoriasis successfully treated with calcipotriol plus betamethasone dipropionate gelDipeptidyl Peptidase-4 Inhibitor-associated Bullous Pemphigoid: Recurrence with Epitope SpreadingCase of psoriatic erythroderma induced by the discontinuation of the chronic use of topical steroid after dialysis initiation and successfully treated with secukinumabMedical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsSuccessful treatment of toenail onychomycosis with photodynamic therapy
P50
Q37188682-CAC436A1-C2AA-4D4F-AC1A-E61B07677C0FQ37638862-280E622D-0A6D-4C09-8474-EDDDE565F571Q38767060-21C0E283-9598-4D72-98A5-62A87DF48299Q40133568-053F8A14-3C3A-4BA3-9BF8-5DE741EDF2A3Q40489272-4B636F78-98CF-4E0C-8818-339D0345D1BDQ45046179-B90EB9E8-7206-4C56-9674-78AF75A524B5Q45272837-710922D5-AD19-4DA2-AC9B-CC6584C8D2AFQ45332034-206FCB04-E56B-4832-9038-4B1CF75B313DQ45411920-8EA040A8-6711-4EEA-A40E-1A75D70D553CQ45739720-1B1BB7FD-83ED-495A-A3FA-B01DCF7EAC10Q46768883-09E84FA4-E979-494E-8A88-BA43D020A832Q48324125-0F2F53AE-5023-426D-BA63-8D222215575FQ49815738-380FA141-6E94-4E9C-AC43-AA3DEEF3F327Q50315286-3CF6D5A9-363B-4E6D-9547-8221D87A84B1Q50356289-E93E3A36-FFD8-4403-AABD-336E58DDA6C1Q50759952-5AB16451-3586-4512-B4E2-58E9C71BA3BBQ53041387-50C100DB-F983-4E29-B4D2-625EC7F2DFFAQ53156925-C30078FC-3A90-4513-8C3C-B62D644782D4Q53213389-94CF3130-E5FE-4F7B-AB8F-DC136C0CE5BAQ54230925-F97C3FFD-F0B0-463F-9C27-C48E818BEF67Q59358924-CE64DA29-1580-4CE3-8537-88E101E9239AQ59358974-846E601D-E735-409A-9A13-9E6246A9AA37Q64952051-BF536008-E14D-46E5-B525-6B4CEF9DB28EQ72991313-0CB54E6C-6F59-4FD6-AE35-8E89ADC2DD9AQ79277267-D22B4108-5804-456A-BA35-E3F833B5FBBAQ81095562-393C6566-91D0-483E-B01D-0F599CF4D5C8Q82551741-9C93F296-C618-4810-84DA-E0B669747778Q83225948-CB27D6E1-03D1-4495-ACFD-DEE1E74A829BQ83911166-792784BA-D0AF-43FC-A7CD-F0A22C0D5DA4Q84099907-2CD7439D-4C51-4BD3-8821-CBF9039E7949Q84595373-518C8A11-27A1-4CA6-9CEF-D2E0DFC072B7Q84975923-22B62320-0368-429C-9180-9CCFC6E748EBQ89433294-8B8251CA-8A39-4708-B778-2425D0202175Q89771552-99671C97-00A1-4785-8204-F2B94BC47E3CQ90441722-69B6D1CF-C7FA-4F2D-A4B7-AE2817E47298Q90809417-302DB59A-C492-4373-8718-5C3D20FFE584Q91537910-3F229199-A3DC-4642-871E-404ABFA43A0FQ92876212-99759D76-3071-4E2F-99C6-ACA491CE53C2Q95788838-52AB0B64-71C7-4A67-9BE3-60442A29161D
P50
description
researcher ORCID ID=0000-0001-6817-3993
@en
name
Daisuke Watanabe
@ast
Daisuke Watanabe
@en
Daisuke Watanabe
@es
Daisuke Watanabe
@nl
type
label
Daisuke Watanabe
@ast
Daisuke Watanabe
@en
Daisuke Watanabe
@es
Daisuke Watanabe
@nl
prefLabel
Daisuke Watanabe
@ast
Daisuke Watanabe
@en
Daisuke Watanabe
@es
Daisuke Watanabe
@nl
P106
P1153
7004438240
P31
P496
0000-0001-6817-3993